Ye Weiguo (CIK 1985496) reported 36 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-22). Recent activity: Buy GYRE (3,000 shares), Sell GYRE (3,000 shares), Buy GYRE (5,000 shares), Sell GYRE (5,000 shares), Buy GYRE (3,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Buy | 3,000 | $2,250 |
| 2026-06-22 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Sell | 3,000 | $18,450 |
| 2026-06-22 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Buy | 5,000 | $3,750 |
| 2026-06-22 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Sell | 5,000 | $31,200 |
| 2026-06-22 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Buy | 3,000 | $2,250 |
| 2026-06-22 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Sell | 3,000 | $19,050 |
| 2026-06-15 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Buy | 2,800 | $2,100 |
| 2026-06-15 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Sell | 2,800 | $17,276 |
| 2026-06-11 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Buy | 14,500 | $10,875 |
| 2026-06-11 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Sell | 14,500 | $89,030 |
| 2026-06-11 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Buy | 6,418 | $4,814 |
| 2026-06-11 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Sell | 6,418 | $39,856 |
| 2026-06-08 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Buy | 19,575 | $14,681 |
| 2026-06-08 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Sell | 19,575 | $119,995 |
| 2026-06-08 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Buy | 15,401 | $11,551 |
| 2026-06-08 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Sell | 15,401 | $98,566 |
| 2026-05-27 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Buy | 3,500 | $2,625 |
| 2026-05-27 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Sell | 3,500 | $21,280 |
| 2026-05-27 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Buy | 4,000 | $3,000 |
| 2026-05-27 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Sell | 4,000 | $24,400 |
| 2026-05-22 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Buy | 9,400 | $7,050 |
| 2026-05-22 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Sell | 9,400 | $57,810 |
| 2026-05-22 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Buy | 12,820 | $9,615 |
| 2026-05-22 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Sell | 12,820 | $78,843 |
| 2026-05-20 | GYRE THERAPEUTICS, INC. (GYRE) | Chief Operating Officer | Buy | 200 | $150 |
Source: SEC Form 4 filings · as of 2026-06-22